Alison Frances Lawton is a director of Spyre Therapeutics, Inc.
Person profile
Roles
Address
Lexington, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
X4 Pharmaceuticals, Inc
11 Jun 24
4
Dianthus Therapeutics, Inc. /DE/
28 May 24
4
Dianthus Therapeutics, Inc. /DE/
13 Sep 23
4
Aeglea BioTherapeutics, Inc.
30 Jun 23
4
X4 Pharmaceuticals, Inc
14 Jun 23
4
Magenta Therapeutics, Inc.
30 Jun 22
4
X4 Pharmaceuticals, Inc
27 Jun 22
4
Aeglea BioTherapeutics, Inc.
10 Jun 22
4
Aeglea BioTherapeutics, Inc.
9 Jun 21
4
Magenta Therapeutics, Inc.
3 Jun 21
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 10 Jun 24 | XFOR X4 Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 45,000 | 0.00 | 96,667 |
| 23 May 24 | DNTH Dianthus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 21.77 | 11,000 | 239.47 k | 11,000 |
| 11 Sep 23 | DNTH Dianthus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 11.2 | 6,500 | 72.80 k | 6,500 |
| 22 Jun 23 | SYRE Spyre Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.3 | 1,950,000 | 585.00 k | 1,950,000 |
| 13 Jun 23 | XFOR X4 Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 45,000 | 0.00 | 51,667 |